New research findings shows that specific bacteria in patients’ gut microbiome correlate with biomarkers that suggest they are at greater risk of heart damage during chemotherapy.  

98 women over the age of 60 diagnosed with breast cancer were tested for biomarkers that indicate heart health and their gut bacteria genome was sequenced before chemotherapy. 

This study is part of a wider project called CARDIOCARE which will allow the research to expand to a larger study of 600 women to confirm the finding. This work offers the hope that tailored probiotics could be used to help protect women from the heart side-effects of chemotherapy in future. 

· Cases of bowel cancer are on the rise, and the chemotherapy drugs used to treat most patients haven’t changed in almost 50 years. These drugs eventually stop working for many patients.

· Until now, scientists haven’t understood how resistance to chemotherapy develops.

· New machine learning technology can determine how resistance has developed, which will accelerate the design of new drugs to keep patients well for longer

In this March 2025 issue of Translational Lung Cancer Research, a pioneering study, led by Professor Shuben Li from the First Affiliated Hospital of Guangzhou Medical University, presents compelling evidence demonstrating the efficacy, accuracy and safety of electromagnetic navigation bronchoscopy-guided dye marking (ENBDM).

The article entitled "A better option for localization of multiple pulmonary nodules in the ipsilateral lung: electromagnetic navigation bronchoscopyguided preoperative localizationl". This retrospective study compared ENBDM with conventional CT-guided percutaneous lung puncture (CTPLP) in 203 patients undergoing thoracoscopic surgery between 2018 and 2023, supporting ENBDM as an optimal strategy for localizing multiple ipsilateral lung nodules.